Realgar‐Induced CNS Toxicity: Exploring OTC‐Mediated Ornithine Regulation of ZBTB7A Inhibits Astrocyte Glycolysis Based on the Liver–Brain Axis

Realgar, an arsenic-containing traditional Chinese medicine, is commonly used in clinical practice. However, prolonged, excessive, or uncontrolled administration of Chinese patent medicines containing realgar can occasionally induce adverse effects. Notably, realgar-induced central nervous system (CNS) toxicity has garnered significant attention. To elucidate the molecular mechanism underlying realgar-induced CNS toxicity, conditional intervention animal models (Zbtb7a<sup>GfABC1D</sup> KD/Otc<sup>TBG</sup> OE/chrysophanol intervention) are established and exposed to realgar, and a C8-D1A astrocyte cell line transfected with si-Zbtb7a is established and exposed to both iAs<sup>3+</sup> and ornithine. Single-cell transcriptome sequencing, metabolomic analysis, as well as neurobehavioral, molecular biological, and histopathological experiments are performed. These results demonstrate that arsenic derived from realgar crosses the blood-brain barrier and accumulates in the frontal lobe. Within astrocytes, arsenic triggers ZBTB7A-mediated transcriptional repression of the glycolytic genes Aldoa, Ldha, and Pgam1, consequently reducing lactic acid levels. This cascade of events culminates in energy deficits within the frontal lobe, promoting apoptosis and oxidative damage. These pathological changes manifest behaviorally as decreased learning and memory capacity, diminished spontaneous exploration, and the development of anxiety-like behaviors. Furthermore, realgar inhibits hepatic ornithine transcarbamylase (OTC), disrupting the hepatic ornithine cycle. This disruption leads to ornithine accumulation, which in turn modulates the transcription factor ZBTB7A in astrocytes, indirectly exacerbating the neurotoxic effects of arsenic. In addition, chrysophanol antagonizes the toxic effects of realgar on the CNS and liver by protecting astrocyte glycolytic function and the hepatic ornithine cycle. This study provides new perspectives and targets for the prevention and treatment of realgar-induced neurological injuries, as well as new experimental bases and theoretical guidance for the use of rhubarb and realgar in traditional Chinese medicine.

Authors

Institutions

Publication Details

Journal
Advanced Science
Published
2025-11-21
DOI
https://doi.org/10.1002/advs.202502591
Primary Topic
Arsenic contamination and mitigation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Realgar‐Induced CNS Toxicity: Exploring OTC‐Mediated Ornithine Regulation of ZBTB7A Inhibits Astrocyte Glycolysis Based on the Liver–Brain Axis

Ping Ye, Zhen Li, Chao Ma, Xingang Cui et al.
Advanced Science
Arsenic contamination and mitigation
article

Realgar‐Induced CNS Toxicity: Exploring OTC‐Mediated Ornithine Regulation of ZBTB7A Inhibits Astrocyte Glycolysis Based on the Liver–Brain Axis

Ping Ye, Zhen Li, Chao Ma, Xingang Cui, Hong Jiang, Chun Song, Huanyong Fu, Shuai Wang
article en

Abstract

Realgar, an arsenic-containing traditional Chinese medicine, is commonly used in clinical practice. However, prolonged, excessive, or uncontrolled administration of Chinese patent medicines containing realgar can occasionally induce adverse effects. Notably, realgar-induced central nervous system (CNS) toxicity has garnered significant attention. To elucidate the molecular mechanism underlying realgar-induced CNS toxicity, conditional intervention animal models (Zbtb7a<sup>GfABC1D</sup> KD/Otc<sup>TBG</sup> OE/chrysophanol intervention) are established and exposed to realgar, and a C8-D1A astrocyte cell line transfected with si-Zbtb7a is established and exposed to both iAs<sup>3+</sup> and ornithine. Single-cell transcriptome sequencing, metabolomic analysis, as well as neurobehavioral, molecular biological, and histopathological experiments are performed. These results demonstrate that arsenic derived from realgar crosses the blood-brain barrier and accumulates in the frontal lobe. Within astrocytes, arsenic triggers ZBTB7A-mediated transcriptional repression of the glycolytic genes Aldoa, Ldha, and Pgam1, consequently reducing lactic acid levels. This cascade of events culminates in energy deficits within the frontal lobe, promoting apoptosis and oxidative damage. These pathological changes manifest behaviorally as decreased learning and memory capacity, diminished spontaneous exploration, and the development of anxiety-like behaviors. Furthermore, realgar inhibits hepatic ornithine transcarbamylase (OTC), disrupting the hepatic ornithine cycle. This disruption leads to ornithine accumulation, which in turn modulates the transcription factor ZBTB7A in astrocytes, indirectly exacerbating the neurotoxic effects of arsenic. In addition, chrysophanol antagonizes the toxic effects of realgar on the CNS and liver by protecting astrocyte glycolytic function and the hepatic ornithine cycle. This study provides new perspectives and targets for the prevention and treatment of realgar-induced neurological injuries, as well as new experimental bases and theoretical guidance for the use of rhubarb and realgar in traditional Chinese medicine.

Advanced ScienceVol. 13(2)
Liaoning University (CN), Mudanjiang Medical University (CN), Shenyang Center for Disease Control and Prevention (CN), Shimadzu (China) (CN), China Medical University (CN)
Openalex Percentile: Top 69%
Arsenic contamination and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.